INTRODUCTION
The γ-aminobutyric acid type A (GABA A ) receptor complex is a pentameric assembly of proteins structured around a chloride ion pore. Depending on protein configuration, GABA A receptors may include benzodiazepine and/or neuroactive steroid binding sites (for review, see Rudolph et al., 2001; Lambert et al., 2009 ).
Pharmacological modulators of GABA A receptors exert their effects by binding to these sites, enhancing the ability of GABA to increase chloride conductance. Positive allosteric modulation of either the benzodiazepine or steroid binding sites results in various neurochemical and behavioral effects, many of which have therapeutic implications.
Benzodiazepines and other positive allosteric modulators with action at the benzodiazepine site of the GABA A receptor are among the most commonly used pharmacotherapies for the treatment of anxiety-and sleep-related disorders, due to their therapeutic effectiveness and favorable side-effect profile. Their clinical utility is compromised, however, by the occurrence of other characteristic effects including daytime drowsiness, impairment of motor coordination, cognitive impairment, and reinforcing effects which are thought to contribute to their potential for abuse. These clinical observations are in concordance with animal models used to predict the therapeutic and side effects of benzodiazepines. As examples, these compounds produce anxiolytic-like effects in rodents and primates and their presentation maintains behavior in animal models of drug self-administration (for review, see Licata and Rowlett, 2008) .
Preclinical studies also suggest that positive modulators with affinity for the neuroactive steroid site of the GABA A receptor produce behavioral effects similar to those observed after benzodiazepine administration. For example, these compounds can This article has not been copyedited and formatted. The final version may differ from this version.
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jpet.aspetjournals.org Downloaded from JPET #180422 5 produce anxiolytic-like effects in rodent ethological (Vivian et al., 1997; Rodgers and Johnson, 1998; Wieland et al., 1995) and conflict models (Wieland et al., 1995; Vanover et al., 1999) , although there are limited published reports on this effect in non-human primates (Vanover et al., 2000) . Further, assays of drug self-administration have been used to demonstrate that neuroactive steroids maintain responding above vehicle levels in both rodents (Sinnott et al., 2002) and non-human primates (Rowlett et al., 1999) .
Interaction studies also suggest that drugs acting at benzodiazepine and neuroactive steroid sites, when administered concurrently, can produce effects that are either additive or deviate from additivity. Interestingly, these effects can depend on the experimental endpoint under study. As examples, isobolographic and/or dose addition analysis have been used to demonstrate that benzodiazepines and neuroactive steroids interact additively when assessed on benzodiazepine drug discrimination (McMahon and France, 2005) , but in a supra-additive manner when assessed on measures of anesthetic action (Norberg et al., 1999) . Clearly, in addition to improving our understanding of GABA A receptor pharmacology, the assessment of benzodiazepine-neuroactive steroid interactions across behavioral endpoints related to anxiety and drug abuse may have important clinical implications.
The purpose of the current study was to assess the behavioral effects of the benzodiazepine triazolam and the neuroactive steroid pregnanolone, both alone and in combination. Triazolam and pregnanolone were chosen as representative of benzodiazepine-type compounds and neuroactive steroids, respectively, with relatively short durations of action (e.g., Puia et al., 1990; Ducic et al. 1993; Carl et al., 1994; Lelas et al., 2001) . The anxiolytic-like and response rate-reducing effects of each drug This article has not been copyedited and formatted. The final version may differ from this version.
JPET Fast Forward. Published on March 16, 2011 as DOI: 10.1124 at ASPET Journals on July 8, 2017 jpet.aspetjournals.org Downloaded from JPET #180422 6 administered alone were first assessed in a rhesus monkey conflict procedure. The conflict procedure provides measures of both anxiolytic-like effects (increases in suppressed responding) and decreases in operant behavior (rate-reducing effects). Next, the reinforcing effects of triazolam and pregnanolone were assessed using a progressiveratio schedule of drug self-administration, which is thought to provide a measure of the relative reinforcing strength of drugs (Stafford et al., 1998) . Finally, to distinguish an additive effect from an infra-or supra-additive interaction, drugs were administered in combination, assessed across each endpoint, and analyzed with dose-addition analysis (Tallarida, 2000) .
This article has not been copyedited and formatted. The final version may differ from this version. 
MATERIALS AND METHODS
Animals. Subjects were six adult male rhesus monkeys (Macaca mulatta) that were housed individually and maintained on a 12-hr lights-on/12-hr lights-off cycle, with water available continuously. Monkeys in the conflict studies were maintained at 90-95% of their free-feeding weights, and monkeys in the self-administration studies were not food-restricted. Monkeys were prepared with a chronic indwelling venous catheter according to the procedures described by Platt et al. (2005) . Animals in this study were maintained in accordance with the "Guide for Care and Use of Laboratory Animals" 85-23, revised 1996) . ,4] benzodiazepine) was purchased from Sigma-Aldrich (St. Louis, MO, USA) and dissolved in 50% propylene glycol, 50% sterile water. Pregnanolone (3α-hydroxy-5β-pregnan-20-one) was purchased from Tocris Cookson (Ellisville, MO, USA), and dissolved initially in 45% (w/v) 2-hydroxypropyl-β-cyclodextrin. Dilutions of pregnanolone were made in 50% propylene glycol, 50% sterile water.
Conflict Procedure. Three rhesus monkeys were trained as described in detail by Rowlett et al. (2006) . A daily session consisted of 4 cycles, each preceded by a 10-min time out period in which all lights in the chamber were off and responding had no Self-administration Procedure. Three rhesus monkeys were trained to selfadminister the benzodiazepine midazolam (0.03 mg/kg/infusion) under a progressive ratio schedule of i.v. drug injection Rowlett and Lelas, 2007) . At the beginning of a daily session, a set of two white stimulus lights above a response lever was illuminated. Upon completion of a response requirement, the white lights were extinguished and a set of two red stimulus lights were illuminated for 1 s, coinciding with a 1-s infusion. Each trial ended with either an injection or the expiration of a 30-min limited hold. Trials were separated by a 30-min timeout period, during which all lights were extinguished and responding had no programmed consequences. The primary dependent measure in the self-administration procedure was the average number of injections per session. Break points were also determined for individual monkeys under each test condition. A break point, defined as the highest response requirement completed during a test session, was used to calculate the maximum break point, which was the highest break point maintained by individual subjects for a compound, irrespective of dose. Dose-effect analysis. The dose of each drug mixture required to produce a 50% decrease in rates of non-suppressed responding, an increase to 50% in rates of suppressed responding, or an increase to 50% of the maximum effect in drug self-administration was derived using log-linear regression when at least three data points were available on the linear portion of the dose-effect curve or by log-linear interpolation when only two data points (one above and one below 50%) were available. These values were obtained by converting the maximum suppression of the rates of non-suppressed responding, the This article has not been copyedited and formatted. The final version may differ from this version. Individual doses on each dose-effect curve were evaluated by conducting a priori Bonferroni t-tests, comparing individual doses to vehicle injection with an alpha level set at p ≤ 0.05. Bonferroni t-tests were also used to evaluate differences in maximum break point values between each drug or drug mixture. To evaluate the relationship between the triazolam and pregnanolone dose-effect curves, a parallel line analysis was conducted as described by Tallarida (2000) . as described by Tallarida (2000) . Z mix was defined as the total drug dose (i.e., dose triazolam + dose pregnanolone) that produced a 50% decrease in rates of non-suppressed responding, an increase to 50% increase in the mean rates of suppressed responding, or an increase to 50% of the maximum effect in drug self-administration. Across all endpoints, the mean experimentally determined ED 50 values (Z mix ) and predicted additive ED 50 values (Z add ) for each mixture were compared with a paired t-test. An interaction index (γ) was also calculated to quantify deviation from additivity for each mixture (Tallarida, 2002) . From this calculation, a γ value of 1 suggests additivity, γ values that approach 0 suggest a greater degree of supra-additivity, and γ values that increase from 1 suggest a greater degree of infra-additivity. On drug self-administration, the addition of pregnanolone did not shift the triazolam dose-effect curve significantly relative to triazolam alone (Fig. 5, top) . Isobolographic presentation of the triazolam + pregnanolone mixtures (Fig. 5, bottom) 
DISCUSSION
The present study assessed the effects of triazolam and pregnanolone in a conflict procedure and in a progressive ratio procedure of drug self-administration, both alone and in combination. When administered alone, both triazolam and pregnanolone produced dose-dependent decreases in non-suppressed responding and maintained drug selfadministration, but only triazolam was effective in increasing rates of suppressed responding. The main finding from these experiments is that mixtures of triazolam and pregnanolone produced supra-additive effects on suppressed responding, whereas these same drug mixtures produced additive effects on non-suppressed responding. Further, when assessed on drug self-administration, mixtures of triazolam and pregnanolone produced additive or infra-additive effects. Together, these data demonstrate that the interactive effects of triazolam and pregnanolone depend uniquely on their relative concentrations and the experimental endpoint under study. These data also raise the possibility that adding a neuroactive steroid to a benzodiazepine may enhance its anxiolytic effects without a concomitant enhancement of reinforcing properties.
Procedures that assess the effects of drugs on experimentally-induced conflict are used often to assess the potential anxiolytic effects of these drugs in humans (Geller and Seifter, 1962; Spealman, 1979; Kleven and Koek, 1999; Rowlett et al., 2006) . In the conflict procedure used in the current study, strong positive correlations between the potency of benzodiazepines to increase suppressed responding and therapeutic doses in humans have been reported (Rowlett, et al., 2006) . Therefore, this model may be particularly predictive of the anxiolytic potency of benzodiazepines, other positive GABA A receptor modulators, and novel drug combinations. In the present study, (Licata et al., 2005) and other clinically available benzodiazepines (Rowlett et al., 2006) . Specifically, triazolam increased suppressed responding to rates comparable to those observed under the non-suppressed condition. In contrast, pregnanolone failed to produce an anti-conflict effect. This finding is surprising given previously reported findings. For example, pregnanolone has been shown to increase suppressed operant responding in rodent conflict procedures (Wieland et al., 1995; Brot et al., 1997) . Similar effects have been observed after synthetic neuroactive steroid administration in rodents (Britton et al., 1991; Wieland et al., 1997) and squirrel monkeys (Vanover et al., 2000) , suggesting that under certain conditions activation of the steroid site on GABA A receptors is sufficient to produce an anti-conflict effect. To our knowledge, the present study is the first to assess the anxiolytic-like effects of pregnanolone in rhesus monkeys, and although the reason for the discrepancy between these previously reported findings and the results reported here are unclear, they may reflect the species differences between the studies. However, this discrepancy may also be due to other procedural differences, including the nature of the reinforcer or shock delivery, or the operant schedule maintaining behavior, among other factors.
The present study is also the first to assess the interactive effects of a benzodiazepine and a neuroactive steroid on experimentally-induced conflict. Based on a dose-additive model, it is expected that pregnanolone would not contribute to the effects of triazolam when the two drugs are administered in combination. In contrast, the addition of pregnanolone produced proportion-dependent leftward shifts in the triazolam dose-effect curve, resulting in either additive or supra-additive effects on suppressed This article has not been copyedited and formatted. The final version may differ from this version. When assessed on drug self-administration, mixtures of triazolam and pregnanolone also engendered self-administration at levels greater than saline, suggesting that each mixture also functions as a positive reinforcer. Further, when maximum break point values are considered, these mixtures were self-administered at levels similar to triazolam and pregnanolone alone, suggesting that triazolam + pregnanolone mixtures have a similar reinforcing strength as their component parts. An interesting finding from the present study is that these drug mixtures produced either mixture-dependent additive or infra-additive reinforcing effects. The detection of an infra-additive effect suggests an antagonistic interaction between two drugs, as the potency of the drug mixture required to maintain self-administration is less than would be predicted based on an additive interaction. This finding provides additional evidence suggesting that the interactive effects of triazolam and pregnanolone are endpoint-dependent.
The behavioral selectivity of triazolam + pregnanolone interactions suggests that there is corresponding selectivity across the receptor mechanisms and/or neural circuits mediating each behavior, rather than a general enhancement of all behavioral effects. The results from these studies not only highlight the importance of assessing drug interactions across endpoints, but also have clear clinical implications. Specifically, the data from the present study suggest that it might be possible to develop benzodiazepine + neuroactive steroid mixtures that interact in a supra-additive manner specifically at receptor mediated systems that underlie the targeted behavior of anxiolysis. The finding that these same This article has not been copyedited and formatted. The final version may differ from this version. Across each of the assays, triazolam + pregnanolone mixtures were also assessed using three different proportions, as deviation from additivity depends often on the relative proportions of the drugs under study (Gessner and Cabana, 1970; Tallarida, 2000) . In agreement with these findings, the nature of the interactive effects of triazolam and pregnanolone on suppressed responding and drug self-administration was dependent on the proportion of pregnanolone in each mixture. For example, mixtures of triazolam and pregnanolone produced additive effects in each assay when assessed at a 1:30 ratio, whereas these same drugs produced effects that deviate from additivity when assessed at a 1:100 ratio. Additional support for proportion-dependent effects arises when the degree of deviation from additivity (γ) is measured (i.e. the interaction index; Tallarida, 2002) .
For example, on suppressed responding, a greater degree of supra-additivity is observed as the proportion of pregnanolone in the mixture is increased. Further, a greater degree of infra-additivity is observed as the proportion of pregnanolone in the mixture is increased on drug self-administration. Together, these data suggest that the interactive effects of a benzodiazepine and neuroactive steroid are not only a property of the drugs under study, but also depend on their relative concentrations.
Benzodiazepines such as triazolam are effective anxiolytics; however, they also have reinforcing effects that are thought to contribute to illicit use. If neuroactive steroids and benzodiazepines interact in a supra-additive manner on endpoints related to anxiolysis while producing infra-additive effects on drug reinforcement, combination 
